Your account is not claimed yet. You can sign up with ORCID to claim your account.

Joaquin Martinez-Lopez (Joaquín Martínez-López, Joaquin Martínez-López)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Rosa María Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Santiago Osorio, José María Sánchez-Pina, Gonzalo Carreño-Tarragona, Noemi Álvarez, María Teresa Gómez-Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Carlos Hernández-Boluda, Joaquin Martinez-Lopez
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. EJHaem 4 (2) (2023)
Yaiza Rodríguez-García, Mónica Martínez-Moreno, Lola Alonso, Anna Sánchez-Vencells, Alicia Arranz, Roger Dagà-Millán, Silvia Sevilla-Movilla, Antonio Valeri, Joaquin Martinez-Lopez, Joaquin Teixidó
Regulation of miRNA expression by α4β1 integrin-dependent multiple myeloma cell adhesion. EJHaem 4 (3) (2023)
Rosa María Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Santiago Osorio, José María Sánchez-Pina, Gonzalo Carreño-Tarragona, Noemi Álvarez, María Teresa Gómez-Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Carlos Hernández-Boluda, Joaquin Martinez-Lopez
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. EJHaem 4 (2) (2023)
Rosa María Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Santiago Osorio, José María Sánchez-Pina, Gonzalo Carreño-Tarragona, Noemi Álvarez, María Teresa Gómez-Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Carlos Hernández-Boluda, Joaquin Martinez-Lopez
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. EJHaem 4 (2) (2023)
Enrique María Ocio, Cristina Motlló, Paula Rodríguez-Otero, Joaquin Martinez-Lopez, Mª José Cejalvo, Jesús Martín-Sánchez, Joan Bladé, Mª Dolores García-Malo, Mª Victoria Dourdil, Aránzazu García-Mateo, Felipe de Arriba, Ramón García-Sanz, Javier de la Rubia, Albert Oriol, Juan-José Lahuerta, Jesús San F Miguel, Maria-Victoria Mateos-Manteca
Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1-acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group. British journal of haematology 192 (3) (2020)
Paul Gerard Richardson, Arnon Nagler, Dina Ben-Yehuda, Ashraf Badros, Parameswaran N Hari, Roman Hájek, Ivan Spicka, Hakan Kaya, Richard LeBlanc, Sung-Soo Yoon, Kihyun Kim, Joaquin Martinez-Lopez, Moshe Mittelman, Ofer Shpilberg, Paul Blake, Teru Hideshima, Kathleen Colson, Jacob P Laubach, Irene M Ghobrial, Merav Leiba, Moshe E Gatt, Peter Sportelli, Michael Chen, Kenneth C Anderson
Randomized, placebo-controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomib. EJHaem 1 (1) (2020)
Rafael Alonso Fernández, María-Teresa Cedena, Adolfo Gómez-Grande, Rafael Ríos, José María Moraleda, Valentín Cabañas, María José Moreno, Javier López-Jiménez, Fernando Martín, Alejandro Sanz, Antonio Valeri, Ana Jiménez, Ricardo Sanchez, Juan José Lahuerta, Joaquin Martinez-Lopez
Imaging and bone marrow assessments improve minimal residual disease prediction in multiple myeloma. American journal of hematology 94 (8) (2019)
Yanira Ruiz-Heredia, Beatriz Sanchez-Vega, Santiago Barrio, María Linares, Inmaculada Rapado, Esteban Braggio, Keith Stewart, M Dolores Folgueira, Ana Ramos, Luis Collado, Juan Ruiz, Oscar Toldos, Aurelio Hernandez-Lain, Joaquin Martinez-Lopez
Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (4) (2018)

Joaquin Martinez-Lopez.css-eqlu8i{font-size:small;padding-left:4px;} (Joaquín Martínez-López, Joaquin Martínez-López)

Publication Activity (10 Years)

Top Topics

Top Venues

Joaquin Martinez-Lopez (Joaquín Martínez-López, Joaquin Martínez-López)